Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
Akari has completed evaluation of long-acting PAS-nomacopan candidates and selected a single drug candidate to…
Akari has completed evaluation of long-acting PAS-nomacopan candidates and selected a single drug candidate to…
Analysis of MRI scans in participants from an open label Phase 1b study demonstrates that CDM®, a novel gray matter biomarker, is improved following three months…
Analysis of MRI scans in participants from an open label Phase 1b study demonstrates that CDM®, a novel gray matter biomarker, is improved following three months…
Composition of matter and use patent for Versamune® in combination with PDS0301 allowed in Canada…
Composition of matter and use patent for Versamune® in combination with PDS0301 allowed in Canada…
Former CEO and Founder, Esther Alegria Remains on Executive Team Focused on Driving Research &…
Former CEO and Founder, Esther Alegria Remains on Executive Team Focused on Driving Research &…
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN…
Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase…
Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase…
Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of…
Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of…
Highlights: First cohort in Phase I/II urinary tract infection (UTI) rapid infusion intravenous (IV) study…
Highlights: First cohort in Phase I/II urinary tract infection (UTI) rapid infusion intravenous (IV) study…
Experienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy Programs MIAMI, July…
Experienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy Programs MIAMI, July…
Joining Adobe, Spotify, Nvidia, Morgan Stanley, and many others BASEL, Switzerland, LONDON, and NEW YORK,…
Science 37’s Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for…
Joining Adobe, Spotify, Nvidia, Morgan Stanley, and many others BASEL, Switzerland, LONDON, and NEW YORK,…